𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activation of nigral dopamine neurons by the selective GABAB-receptor antagonist SCH 50911

✍ Scribed by S. Erhardt; H. Nissbrandt; G. Engberg


Publisher
Springer
Year
1999
Tongue
English
Weight
188 KB
Volume
106
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


GABAB-Receptor activation alters the fir
✍ GΓΆran Engberg; Torben Kling-Petersen; Hans Nissbrandt πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 1021 KB

Previous electrophysiological experiments have emphasized the importance of the firing pattern for the functioning of midbrain dopamine (DA) neurons. In this regard, excitatory amino acid receptors appear to constitute an important modulatory control mechanism. In the present study, extracellular re

Differential modulation of dopamine D1-r
✍ Jiang Yu; HΓ©ctor Coirini; Lillemor KΓ€llstrΓΆm; Frits-Axel Wiesel; Allan E. Johnso πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 333 KB πŸ‘ 2 views

Dopamine D 1 -receptor binding in the basal ganglia is differentially regulated by subtype nonspecific dopamine antagonists such as the antipsychotic, Fluphenazine. The purpose of the present study was to determine the relative contributions of D 1 and D 2 receptor systems in the regulation of basal

Direct demonstration of D1 dopamine rece
✍ Dr. Frederick J. Monsma Jr.; David R. Sibley πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 706 KB

The presence of D, dopamine receptors in the parathyroid gland has been proposed based on the demonstration of dopaminergic regulation of adenylate cyclase activity and parathyroid hormone release in dispersed bovine parathyroid cells. Using a radioiodinated D, selective antagonist [12511-SCH 23982,

Comparison of the effects of the cholecy
✍ Leonard T. Meltzer; Curt L. Christoffersen; Kevin A. Serpa; Ahmad Razmpour πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 686 KB

Extracellular single-unit recording techniques were used to study the effects of the cholecystokinin-A (CCK-A) antagonist, L-364,718, and the CCK-B antagonist, PD 134308, on DA neuronal activity in chloral hydrate anesthetized rats. Neither L-364,718 (0.1-1.6 m g k g i.v.) nor PD 134308 (0.1-6.4 mgk